Contraceptive Methods — India Complete Guide

India's Total Fertility Rate (TFR) has fallen to 2.0 (NFHS-5, 2019-21) — below replacement level of 2.1. However, 5 states (Bihar, UP, Jharkhand, Manipur, Meghalaya) still have TFR > 2.5. Mission Parivar Vikas (MPV, 2017) targets these states with intensified family planning services.

Contraceptive prevalence rate (modern methods) in India: 56% (NFHS-5). Method mix: female sterilisation 38%, male sterilisation 0.3%, IUCD 2%, OCP 9%, condom 9%, others < 1%. India's heavy reliance on female sterilisation is a structural concern — calls for greater spacing method uptake.

IUCD (Intrauterine Contraceptive Device):

• Cu-T 380A: Copper-bearing IUCD, FDA approved for 10 years. Insertion at any time (post-abortion, postpartum > 6 weeks, interval). Effectiveness: 99.2%.
• Postpartum IUCD (PPIUCD): Inserted within 48 hours of delivery by trained provider — Copper T 380A safe, effective.
• Hormonal IUCD (Levonorgestrel — Mirena): Not widely available in public sector. Lighter periods, 5-year efficacy.
• Side effects: Heavier menstrual bleeding (Cu-T), cramping, expulsion (5%), perforation (rare < 1/1000)

Oral Contraceptive Pills (OCP):

• Combined OCP (COC): Ethinyl estradiol 30 mcg + Levonorgestrel 150 mcg (or Desogestrel). Take 1 daily x 21 days, then 7-day pill-free interval. Monophasic, biphasic, triphasic available. Effectiveness: 99.7% with perfect use, 91% typical use.
• Progestin-only pill (POP): Norethisterone 0.35 mg or Desogestrel 75 mcg. Safe in breastfeeding, no estrogen contraindications. Take at SAME TIME daily (within 3-hour window).
• Emergency contraception: Levonorgestrel 1.5 mg single dose within 72 hours of unprotected intercourse (or 0.75 mg x 2 doses 12 hours apart). Ulipristal acetate 30 mg within 120 hours. Mifepristone 10 mg — single dose within 72 hours (less common in India).

Injectable DMPA (Medroxyprogesterone acetate): 150 mg IM every 3 months. Effectiveness 99%. Side effects: irregular bleeding, weight gain, amenorrhoea, delayed return to fertility (6-12 months). Introduced in public sector in 2017.

Subdermal Implant (Implanon NXT): Etonogestrel 68 mg single rod inserted subdermally in upper arm. 3-year efficacy. Available in private sector in India.

Condom (male, female): Only method that protects against STIs/HIV. Effectiveness: 98% perfect use, 85% typical use. Free in public sector. Female condom (FC2) — less popular.

Female sterilisation (Tubectomy):

• Mini-lap: Pomeroy technique through sub-umbilical mini-incision, postpartum within 7 days or interval at 6 weeks postpartum. Spinal anaesthesia. Day-care procedure.
• Laparoscopic: Day-care, single puncture, Falope ring application. Interval procedure only (not postpartum).
• Effectiveness: 99.5%. Failure rate 0.5%. Permanent — counselling essential.
• Eligibility: Woman ≥ 22 years, parity ≥ 2, both partners consent. Cooling-off period of 72 hours after consent. Acceptor fee Rs 600 (centre) + Rs 250 (state) — varies.

Male sterilisation (Vasectomy):

• No-scalpel vasectomy (NSV): Single puncture technique, no stitches, day-care. Local anaesthesia. Faster recovery than tubectomy.
• Effectiveness: 99.85%. Need alternative contraception for 12 weeks / 20 ejaculations after procedure until semen analysis confirms azoospermia.
• Acceptance in India is very low (< 0.5% of couples). Cultural barriers — men reluctant to take responsibility.
• Higher acceptor fee (Rs 1100 centre + Rs 1000 state) under Mission Parivar Vikas to incentivise male participation.

• Calendar method (rhythm): Avoid intercourse during fertile period (days 10-19 in 28-day cycle). 75-87% effective.
• Basal body temperature method: Body temperature rises 0.2-0.5°C after ovulation. Avoid intercourse until 3 days after temperature rise.
• Cervical mucus method (Billing's): Track cervical mucus changes — fertile mucus is clear, slippery, stretchy. Avoid intercourse when fertile mucus appears.
• Symptothermal method: Combines calendar, BBT, cervical mucus.
• Lactational Amenorrhoea Method (LAM): 98% effective if 3 conditions met: (1) exclusive breastfeeding day and night, (2) amenorrhoea, (3) baby < 6 months old. Transition to other method at 6 months or when menses returns.
• Withdrawal (coitus interruptus): 78% effective typical use. Not recommended as primary method.

Contraceptive knowledge is essential for every Indian doctor — family planning is a fundamental component of primary care. For UPSC CMS aspirants, IUCD, OCP categories, sterilisation eligibility, and Mission Parivar Vikas are highly testable topics.